Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Patent
1997-04-23
1999-11-09
Naff, David M.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
424422, 424499, 435176, 435177, 435178, 435395, 435403, C12N 500, C12N 1102, C12N 1110, C12N 506
Patent
active
059808888
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
1. Field of the Invention
The subject-matter of the invention is a new biomaterial which contains epithelial cells on microcarriers (MCs), as well as the preparation and use of said biomaterial for preparing a medicament.
2. Description of the Prior Art
Skin consists of the epidermis, the basement membrane and the dermis. The epidermis forms the outer coat. The dermis consists essentially of fibroblasts with additional substances such as, e.g., collagen. The basement membrane essentially contains keratinocytes which are non-differentiated but proliferating. The epidermis essentially contains differentiated keratinocytes wherein the upper layer is horny. It is true that while the degree of differentiation of the cells is increasing, the ability of the cells to proliferate is decreasing. Accordingly, the non-differentiated keratinocytes exhibit the highest proliferation potency.
Burn wounds and slow-healing wounds (ulcers) usually are treated with skin sheets consisting of autologous keratinocytes (classical method). To this end, a piece of skin is cut off from the patient, the keratinocytes are cultured in vitro, and the expanded skin sheets so obtained are transplanted [Gallico, G. G., et al., New Engl. J. Med. 311 (1984) 448-451 (1); Cuono, C., et al., Lancet (1986) 1123-1124 (2); De Luca, M., et al., Burns 15 (5) (1989) 303-309 (3); Gallico, G. G., Clinics in Plastic Surgery 17 (3) (1990) 519-526 (4); De Luca, M., and Cancedda, R., Burns 18 (1) (1992) 5-9 (5)]. The transfer of thin skin sheets from cell culture flasks to, e.g., Vaseline gauze as well as the fixing thereof onto the wound surface is problematical. The covering of wounds on parts of the body that are difficult to reach is another problem. Besides this, only keratinocytes can be transferred by means of such classical skin sheets. Skin sheets from keratinocytes involve the drawback that these cells are almost completely differentiated when the sheets are being formed, which means that the sheets practically no longer contain any keratinocytes capable of proliferation. Thus, these sheets constitute a transplantation material which cannot grow, or continue growing, after transplantation. Epidermal transplants (classical skin sheets) with allogenic keratinocytes have been carried out in a number of clinics without any immunological rejection reactions being observed (Gboyse, S. T., et al., Plast. Reconst. Surg. 91 (1993) 632 (17); Burt, A. M., et al., Br. Med. J. 298 (1989) 915 (18); Hickerson, W. L., et al., Burns 20/1 (1994) 52 (19)).
From WO 92/06179 (6) and EP-A 0 242 270 (7) biomaterials are known which contain epithelial cells within a collagen gel. In this context, epithelial cells (fibroblasts or keratinocytes) are embedded in gel layers. It is known that such gels may also contain keratinocytes. However, the keratinocytes in the gel are immobilized and are thus incapable of proliferating and differentiating to an appreciable extend after transplantation. Accordingly, keratinocytes from such gels are not able to form a basement membrane and an epidermis. Another drawback of this biomaterial is, in particular, the low rate of migration of the epithelial cells from the biomaterial into the wound. Furthermore, the handling and fixing of these biomaterials is very difficult and laborious.
In WO 90/02796 (8) there is described a three-dimensional cell culture system on the basis of, for instance, cellulose, polyamide, polyester, on which epithelial cells can grow. In this context, an artificial tissue is obtained which is covered with epithelial cells (fibroblasts or keratinocytes) and which is said to be suitable for transplantation. These artificial transplantation materials, too, do not exhibit any advantage over the skin sheets applied in the classical method.
SUMMARY OF THE INVENTION
The object of the invention is to provide a biomaterial which does not exhibit the drawbacks described and which can be prepared in an easy manner and in large quantities. The subject-matter of the invention is the use of a bi
REFERENCES:
patent: 4016036 (1977-04-01), Green
patent: 4940666 (1990-07-01), Boyce et al.
patent: 5709854 (1998-01-01), Griffith-Cima et al.
patent: 5712163 (1998-01-01), Parenteau et al.
International Publication No. WO 81/00260 published Feb. 5, 1981.
International Publication No. WO 89/03228 published Apr. 20, 1989.
International Publication No. WO 89/03392 published Apr. 20, 1989.
International Publication No. WO. 89/08467 published Sep. 21, 1989.
International Publication No. WO 90/02796 published Mar. 22, 1990.
International Publication No. WO 90/13625 published Nov. 15, 1990.
International Publication No. WO 92/06179 published Apr. 16, 1992.
International Publication No. WO 93/10217 published May 27, 1993.
International Publication No. WO 93/23088 published Nov. 25, 1993.
Altankov et al., J. Biomater. Sci. Polymer Edn, vol. 2, No. 2, 1991, pp. 81-89. "Synthesis of protein-coated gelatin microspheres and their use . . .".
Boyce et al., Surgery, vol. 103, No. 4, (Apr.) 1988, "Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes . . .".
Database WPI, Section Ch, Week 9436, Derwent Publications Ltd., London; Class B04, AN 94-292256, 1994.
Database WPIL, Week 9244, Derwent Publications Ltd., London, GB; AN 92-360004, 1992.
Lausanne International Congress on Burns, Jun. 25-28, 1991, Lausanne, Switzerland; The International Society for Burn Injuries; Abstract: N. Serdev et al., "Keratinocytes adhered on collagen microcarriers for burn treatment".
The Jerusalem International Meeting on Burn Injuries, Jerusalem, Israel, Jun. 9-12, 1992; Abstract: N. Serdev et al. "Artificial skin formation in vivo using a composite keratinocyte/collagen graft. 1. Hystological findings and clinical cases".
Tinois et al., Arch. Dermatol. Res., 279, 1987, pp. 241-246, "Growth and differentiation of human keratinocytes on extracellular matrix".
Tinois et al., Experimental Cell Research, 193, 1991, pp. 310-319, "In Vitro and Post-transplantation Differentiation of Human Keratinocytes . . .".
Wilke and Furcht, The Journal of Investigative Dermatology, vol. 95, No.3 (Sep.) 1990, pp. 264-270, "Human Keratinocytes Adhere to a Unique Heparin-Binding Peptide Sequence Within the Triple Helical Region of Type IV Collagen".
Williams et al., Journal of Cellular Physiology, 136, 1988, pp. 103-110, "Lipid Content and Metabolism of Human Keratinocyte Cultures Grown at the Air-Medium Interface".
Dimoudis Nikolaos
Hartinger Anton
Naff David M.
Roche Diagnostics GmbH
LandOfFree
Keratinocytes attached to microcarriers for treatment of skin wo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Keratinocytes attached to microcarriers for treatment of skin wo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Keratinocytes attached to microcarriers for treatment of skin wo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1451790